RecruitingNot ApplicableNCT05715047
Intervention for Fatigue in HCT Recipients
Reducing Persistent Fatigue Following Hematopoietic Stem Cell Transplantation
Sponsor
Massachusetts General Hospital
Enrollment
66 participants
Start Date
Nov 29, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to assess whether a cognitive-behavioral therapy (CBT) for fatigue intervention is acceptable, feasible, and effective at managing fatigue and improving quality of life for patients following hematopoietic stem cell transplant (HCT).
Eligibility
Min Age: 18 Years
Inclusion Criteria7
- adult patients (≥ 18 years)
- have the ability to speak and read English
- have undergone autologous or allogeneic transplant > 6 months prior to enrollment
- no evidence of disease relapse requiring therapy
- no new other malignancy requiring therapy after transplant
- report moderate to severe fatigue in the past week (FSI average severity item rating ≥ 4 of 0-10)
- are currently receiving their care at the MGH Blood and Marrow Transplant Clinic
Exclusion Criteria4
- Patients with active cognitive impairment or uncontrolled psychiatric illness such as schizophrenia that the treating clinician believes prohibits informed consent or participation in the intervention
- Patients already receiving CBT care
- Patients living with untreated sleep apnea
- Patients with hypoxemia requiring oxygen supplementation
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
BEHAVIORALCBT for Fatigue
10, individualized counseling sessions with a behavioral health counselor via Zoom platform.
BEHAVIORALUsual Care
Standard transplant care.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05715047
Related Trials
Mindfulness Intervention for Sleep Disturbance and Symptom Management in Hematologic Cancer Patients During and After Inpatient Treatment
NCT065327731 location
Allergy Delabeling in Antibiotic Stewardship - Intervention
NCT071330741 location
Feasibility and Acceptability of Primary Palliative Care Intervention in Patients Undergoing Hematopoietic Stem Cell Transplantation
NCT066768521 location
Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy
NCT056465761 location
Reduced Intensity Fludarabine and TBI Prior to Haplo-Identical Transplantation
NCT054179711 location